Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 2
2001 1
2002 1
2003 1
2005 1
2006 1
2010 1
2011 2
2012 3
2013 1
2014 3
2015 4
2016 3
2017 3
2018 2
2019 4
2020 3
2021 1
2022 1
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
A novel thymoma-associated autoimmune disease: Anti-PIT-1 antibody syndrome.
Bando H, Iguchi G, Okimura Y, Odake Y, Yoshida K, Matsumoto R, Suda K, Nishizawa H, Fukuoka H, Mokubo A, Tojo K, Maniwa Y, Ogawa W, Takahashi Y. Bando H, et al. Among authors: mokubo a. Sci Rep. 2017 Feb 20;7:43060. doi: 10.1038/srep43060. Sci Rep. 2017. PMID: 28216655 Free PMC article.
A Study of Seasonal Variation in the Effect of Add-On Sitagliptin on Blood Glucose Control in Insulin-Treated Patients With Type 2 Diabetes.
Takai M, Ishikawa M, Maeda H, Kubota A, Iemitsu K, Umezawa S, Kawata T, Takuma T, Takeda H, Tanaka K, Machimura H, Minagawa F, Mokubo A, Motomiya T, Kanamori A, Matsuba I. Takai M, et al. Among authors: mokubo a. J Clin Med Res. 2020 Mar;12(3):200-208. doi: 10.14740/jocmr4103. Epub 2020 Mar 2. J Clin Med Res. 2020. PMID: 32231757 Free PMC article.
A mitochondrial DNA variant associated with left ventricular hypertrophy in diabetes.
Momiyama Y, Furutani M, Suzuki Y, Ohmori R, Imamura S, Mokubo A, Asahina T, Murata C, Kato K, Anazawa S, Hosokawa K, Atsumi Y, Matsuoka K, Kimura M, Kasanuki H, Ohsuzu F, Matsuoka R. Momiyama Y, et al. Among authors: mokubo a. Biochem Biophys Res Commun. 2003 Dec 19;312(3):858-64. doi: 10.1016/j.bbrc.2003.10.195. Biochem Biophys Res Commun. 2003. PMID: 14680844 Clinical Trial.
Is a switch from insulin therapy to liraglutide possible in Japanese type 2 diabetes mellitus patients?
Kawata T, Kanamori A, Kubota A, Maeda H, Amamiya H, Takai M, Kaneshige H, Minagawa F, Iemitsu K, Kaneshiro M, Ishikawa M, Takeda H, Takuma T, Mokubo A, Machimura H, Obana M, Miyakawa M, Naka Y, Suzuki D, Terauchi Y, Toyoda M, Tanaka Y, Matsuba I. Kawata T, et al. Among authors: mokubo a. J Clin Med Res. 2014 Apr;6(2):138-44. doi: 10.14740/jocmr1719w. Epub 2014 Feb 6. J Clin Med Res. 2014. PMID: 24578756 Free PMC article.
Polymorphism of the solute carrier family 12 (sodium/chloride transporters) member 3, SLC12A3, gene at exon 23 (+78G/A: Arg913Gln) is associated with elevation of urinary albumin excretion in Japanese patients with type 2 diabetes: a 10-year longitudinal study.
Nishiyama K, Tanaka Y, Nakajima K, Mokubo A, Atsumi Y, Matsuoka K, Watada H, Hirose T, Nomiyama T, Maeda S, Kawamori R. Nishiyama K, et al. Among authors: mokubo a. Diabetologia. 2005 Jul;48(7):1335-8. doi: 10.1007/s00125-005-1785-4. Epub 2005 May 25. Diabetologia. 2005. PMID: 15915338
Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study.
Matsuba I, Kawata T, Iemitsu K, Asakura T, Amemiya H, Ishikawa M, Ito S, Kaneshiro M, Kanamori A, Kubota A, Shinoda K, Takai M, Takuma T, Takihata M, Takeda H, Tanaka K, Matsuzawa Y, Machimura H, Minagawa F, Minami N, Mokubo A, Miyakawa M, Terauchi Y, Tanaka Y. Matsuba I, et al. Among authors: mokubo a. J Diabetes Investig. 2020 Sep;11(5):1248-1257. doi: 10.1111/jdi.13248. Epub 2020 Apr 25. J Diabetes Investig. 2020. PMID: 32149469 Free PMC article.
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease.
Tsukamoto S, Kobayashi K, Toyoda M, Hatori N, Kanaoka T, Wakui H, Sakai H, Furuki T, Chin K, Ito S, Suzuki D, Umezono T, Aoyama T, Nakajima S, Hishiki T, Hatori Y, Hayashi M, Shimura H, Minagawa F, Mokubo A, Takihata M, Sato K, Miyakawa M, Terauchi Y, Tamura K, Kanamori A. Tsukamoto S, et al. Among authors: mokubo a. Hypertens Res. 2024 Mar;47(3):628-638. doi: 10.1038/s41440-023-01464-y. Epub 2023 Oct 17. Hypertens Res. 2024. PMID: 37848562
35 results